{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe study associated with PMID"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "investigated the mechanism of arachidonic acid (AA) release in mouse spleen cells, demonstrating that Group X secretory phospholipase A2 (sPLA2‑X) triggers a potent release of AA and the subsequent formation of prostaglandin E2 independently of the cytosolic phospholipase A2α (cPLA2α) pathway. Using both pharmacological inhibitors (such as the cPLA2α‑specific inhibitor Pyrrophenone) and cPLA2α‑deficient mice, the researchers provided compelling evidence that sPLA2‑X’s action is not diminished even when cPLA2α is inhibited or absent. Notably, the abstract does not offer any information or insights regarding the function of NPIPB2, and therefore, no functional role for NPIPB2 in this context can be derived from the presented findings.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Akihiko Saiga, Naonori Uozumi, Takashi Ono, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Group X secretory phospholipase A2 can induce arachidonic acid release and eicosanoid production without activation of cytosolic phospholipase A2 alpha."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostaglandins Other Lipid Mediat (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prostaglandins.2004.10.001"}], "href": "https://doi.org/10.1016/j.prostaglandins.2004.10.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15789617"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15789617"}]}]}]}